These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7864905)
41. Production of human monoclonal antibodies by the epstein-barr virus method. Steinitz M Methods Mol Biol; 2014; 1060():111-22. PubMed ID: 24037838 [TBL] [Abstract][Full Text] [Related]
42. Anti-immunoglobulin inhibits DNA synthesis in Epstein-Barr virus-transformed lymphoblastoid cell lines. Gordon J; Melamed MD; Ley SC; Hughes-Jones NC Immunology; 1984 May; 52(1):79-85. PubMed ID: 6325331 [TBL] [Abstract][Full Text] [Related]
44. Human anti-pneumococci antibody produced by an Epstein Barr virus (EBV)-immortalized cell line. Steinitz M; Tamir S; Goldfarb A J Immunol; 1984 Feb; 132(2):877-82. PubMed ID: 6317751 [TBL] [Abstract][Full Text] [Related]
45. [Preparation of human monoclonal antibodies reactive with human melanoma and the possibility of clinical application]. Yamaguchi H Gan To Kagaku Ryoho; 1988 May; 15(5):1677-84. PubMed ID: 2835935 [TBL] [Abstract][Full Text] [Related]
46. Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus. Ueki Y; Goldfarb IS; Harindranath N; Gore M; Koprowski H; Notkins AL; Casali P J Exp Med; 1990 Jan; 171(1):19-34. PubMed ID: 2153188 [TBL] [Abstract][Full Text] [Related]
47. EBV-transformation of surface IgA-positive human lymphocytes. Steinitz M; Klein G J Immunol; 1980 Jul; 125(1):194-6. PubMed ID: 6247394 [TBL] [Abstract][Full Text] [Related]
48. Immunoglobulin-secreting cells in cord blood: effects of Epstein-Barr virus and interleukin-4. Gudmundsson KO; Thorsteinsson L; Gudmundsson S; Haraldsson A Scand J Immunol; 1999 Jul; 50(1):21-4. PubMed ID: 10404047 [TBL] [Abstract][Full Text] [Related]
49. Selective induction of autoantibody secretion in human bone marrow by Epstein Barr virus. Fong S; Vaughan JH; Tsoukas CD; Carson DA J Immunol; 1982 Nov; 129(5):1941-5. PubMed ID: 6288800 [TBL] [Abstract][Full Text] [Related]
50. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for the "forbidden clone" theory. Knight J; Laing P; Knight A; Adams D; Ling N J Clin Endocrinol Metab; 1986 Feb; 62(2):342-7. PubMed ID: 2867105 [TBL] [Abstract][Full Text] [Related]
51. Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein-Barr Virus Reactivation. Kumata K; Nagata K; Matsushita M; Kuwamoto S; Kato M; Murakami I; Fukata S; Hayashi K Viral Immunol; 2016 Oct; 29(8):459-463. PubMed ID: 27529807 [TBL] [Abstract][Full Text] [Related]
52. Human IgG and IgM monoclonal antibodies against autologous melanoma produced by Epstein-Barr-virus-transformed B lymphocytes. Kirkwood JM; Robinson JE Cancer Immunol Immunother; 1990; 32(4):228-34. PubMed ID: 2175672 [TBL] [Abstract][Full Text] [Related]
53. Human monoclonal antibodies reactive with cell surface antigens on human leukemia cell lines: many antibodies are (auto)antibodies. Posner MR; Elboim HS; Tumber MB; Cannon TJ Hybridoma; 1990 Apr; 9(2):97-110. PubMed ID: 2161404 [TBL] [Abstract][Full Text] [Related]
54. Clones producing antibodies of more than one class. Kolb H; Bosma MJ Immunology; 1977 Oct; 33(4):461-7. PubMed ID: 562846 [TBL] [Abstract][Full Text] [Related]
55. Presence of Epstein-Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves' disease patients and in healthy individuals. Nagata K; Higaki K; Nakayama Y; Miyauchi H; Kiritani Y; Kanai K; Matsushita M; Iwasaki T; Sugihara H; Kuwamoto S; Kato M; Murakami I; Nanba E; Kimura H; Hayashi K Autoimmunity; 2014 May; 47(3):193-200. PubMed ID: 24467196 [TBL] [Abstract][Full Text] [Related]
56. Transformation of human colostrum lymphocytes with Epstein-Barr virus and the production of IgA in culture. Maeda-Takekoshi F; Takekoshi M; Tanaka S; Watanabe Y; Dosako S; Kikuchi E Tokai J Exp Clin Med; 1984 Jun; 9(2):103-8. PubMed ID: 6100146 [TBL] [Abstract][Full Text] [Related]
57. The use of Epstein-Barr virus transformation for the production of human monoclonal antibodies. Roome AJ; Reading CL Exp Biol; 1984; 43(1):35-55. PubMed ID: 6099808 [TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs. Garzelli C; Taub FE; Scharff JE; Prabhakar BS; Ginsberg-Fellner F; Notkins AL J Virol; 1984 Nov; 52(2):722-5. PubMed ID: 6092698 [TBL] [Abstract][Full Text] [Related]
59. Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. Kozbor D; Roder JC J Immunol; 1981 Oct; 127(4):1275-80. PubMed ID: 6268704 [No Abstract] [Full Text] [Related]
60. Immune responses in stroma and basement membranes of the Graves' disease thyroid(IgM; IgE, IgG, and complement). Werner SC; Wegelius O; Hsu KC Trans Assoc Am Physicians; 1971; 84():139-43. PubMed ID: 4950610 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]